Clinical Applications for Time-Compressed Speech Tests

NCT ID: NCT00371839

Last Updated: 2014-12-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

78 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-09-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effects of age-related cognitive changes on hearing aid benefit based on hearing aid compression time constants.

The hypothesis is that people with poor working memory skills will benefit from slow time constants in hearing aid compression while those with good working memory skills will be able to benefit from more sophisticated compression algorithms with rapid time constants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recent research has shown the relevance of cognitive function in hearing aid evaluation and the sensitivity of the aging auditory system to temporal distortions. The proposed investigation will examine the interaction of working memory and hearing aid compression method on speech recognition in background competition for older listeners. This interaction will be investigated for the following three forms of background competition:

1. Competition from continuous speech-shaped noise.
2. Competition from speech-modulated noise.
3. Competition from a single interfering talker.

The goals of the study will be accomplished in two phases. In the first phase, 160 adults aged 50 through 75 years will be evaluated on a battery of tests to determine their cognitive capacity, time-compressed speech scores and their candidacy for inclusion in the second phase of the study. At the conclusion of this phase of testing, the participants will be divided into three groups:

1. subjects with TCS test scores in the highest quartile (the HIGH group)
2. subjects with TCS test scores in the lowest quartile (the LOW group)
3. the remaining listeners

The second phase of the experiment will include listeners from the HIGH and LOW groups only. These subjects will be evaluated with respect to their speech recognition ability for three types of interference (steady-state noise, speech-modulated noise, single interfering talker). The HINT test (Nilsson, Soli, \& Sumida, 1995; Nilsson et al., 1994) will be used to obtain the signal-to-noise ratio (SNR) at 50% recognition for the three masking conditions for each of three types of amplification:

1. one- channel linear amplification (LINEAR) with frequency shaping
2. two-channel wide dynamic range compression with fast time constants (FAST)
3. two-channel wide dynamic range compression with slow time constants (SLOW) Listener groups will be compared across hearing aid conditions and across background interference conditions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Loss

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hearing Loss Hearing Aids Rehabilitation of hearing impaired

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mild Hearing Loss

Audiological Evaluation will show average hearing threshold at 500, 1000, 2000, and 4000 Hz of 20-39 decibels hearing level (dBHL)

Group Type ACTIVE_COMPARATOR

Audiological Evaluation

Intervention Type PROCEDURE

Tests of hearing, cognition, and speech perception

Moderate Hearing Loss

Audiological Evaluation will show average hearing threshold at 500, 1000, 2000, and 4000 Hz of 40-49 decibels hearing level (dBHL)

Group Type ACTIVE_COMPARATOR

Audiological Evaluation

Intervention Type PROCEDURE

Tests of hearing, cognition, and speech perception

Moderate-Severe Hearing Loss

Audiological Evaluation will show average hearing threshold at 500, 1000, 2000, and 4000 Hz greater than 50 decibels hearing level (dBHL)

Group Type ACTIVE_COMPARATOR

Audiological Evaluation

Intervention Type PROCEDURE

Tests of hearing, cognition, and speech perception

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Audiological Evaluation

Tests of hearing, cognition, and speech perception

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants will be 50 to 75 years old.
* Hearing loss will be limited to 40 dB HL from 250 Hz through 1000 Hz, and to 60 dB HL through 4000 Hz.
* Hearing loss must be greater than 25 dB at two or more frequencies from 250 to 4000 Hz.

Exclusion Criteria

* None of the participants will be current or past hearing aid users; all will be free of ear disease.
* Participants with conductive hearing losses, defined as air-bone gap greater than 15 dB, will be excluded.
* The audiometric battery with acoustic reflex thresholds and decay measurements will be used to exclude anyone with evidence of a central disorder or a pathology other than a sensorineural loss. Those potential participants will be referred to a medical professional.
Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

US Department of Veterans Affairs

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marjorie R. Leek, PhD

Role: PRINCIPAL_INVESTIGATOR

VA Loma Linda Healthcare System, Loma Linda, CA

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.ncrar.research.va.gov/Index.asp

This is the web page of the VA research Center where the study took place

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C4338-R

Identifier Type: -

Identifier Source: org_study_id